ASTHMA & COPD

The global market for asthma and chronic obstructive pulmonary disease (COPD) prescription drugs was valued at $34.9 billion in 2011. This figure is projected to reach $38 billion in 2012 and $47.1 billion in 2017, increasing at a five-year compound annual growth rate (CAGR) of 4.4%. {http://www.bccresearch.com/}

There’s evidence that people who eat diets higher in vitamins C and E, beta-carotene, flavonoids, magnesium, selenium, and omega-3 fatty acids have lower rates of ASTHMA. Many of these substances are antioxidants, which protect cells from damage.